Tag: Neurology
FDA Delays Decision on New Alzheimer’s Drug
By Robin Foster HealthDay Reporter
FRIDAY, March 8, 2024 (HealthDay News) -- Instead of approving the new Alzheimer's drug donanemab this month, as was expected,...
Biogen Is Dropping Controversial Alzheimer’s Drug Aduhelm
By Ernie Mundell HealthDay Reporter
WEDNESDAY, Jan. 31, 2024 (HealthDay News) -- Biogen, maker of the Alzheimer's medicine Aduhelm, announced Wednesday that it would "discontinue...
Elon Musk Says First Human Has Received Neuralink Brain Implant
By Robin Foster HealthDay Reporter
WEDNESDAY, Jan. 31, 2024 (HealthDay News) -- Elon Musk, co-founder of Neuralink, said this week that the company placed the...
Disparities Identified in Worldwide Neurosurgeon Workforce
Density of neurosurgery trainees higher in high-income countries than low-, lower-middle-, upper-middle-income countries
Human ‘Brain Cell Atlas’ Brings New Insight Into Brain Health, Illness
By Amy Norton HealthDay Reporter
THURSDAY, Oct. 12, 2023 (HealthDay News) -- After a massive five-year effort, researchers have unveiled an âatlasâ that gives an...
New Clues to How Inflammation in Young Children’s Brains Might Spur Autism
By Ernie Mundell HealthDay Reporter
THURSDAY, Oct. 12, 2023 (HealthDay News) -- Severe inflammation very early in childhood might hamper the development of key brain...
El medicamento para la narcolepsia podría ser una nueva opción de tratamiento para el...
By Liamar Healthcare and Denise Mann HealthDay Reporters
JUEVES, 12 de octubre de 2023 (HealthDay News) -- Un medicamento ya aprobado para la somnolencia diurna...
17 Percent of Patients Seeing Neurologist Travel Long Distance
Factors associated with long-distance travel include low neurologist density, rural setting, and visits for ALS, nervous system cancer
No Change Seen in Frequency of Recurrent Vertigo Attacks Over Time
Attack frequency did not change over three years for people with benign recurrent vertigo, Meniere disease, or vestibular migraine
Rates of Tx Retention for Rifaximin Low Despite Benefits for Hepatic Encephalopathy
Lower treatment retention rates seen with 30-day, out-of-pocket costs ≥$150